Clinical trial

Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy

NCT00312442

Study summary

ClinicalTrials.gov

Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2, PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Treatment with WST09 Vascular Photodynamic therapy Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2006-05-01

PhasePHASE2 / PHASE3

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

Treatment with WST09 Vascular Photodynamic therapyDRUG

Sponsors & collaborators

STEBA Francelead sponsor

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00312442 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.